Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 4, 2008, Pages 1246-1253

  Bech, Paul ^a   Winstanley, Virginia ^a   Murphy, Kevin G ^a   Sam, Amir H ^a   Meeran, Karim ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CHROMOGRANIN A; CHROMOGRANIN B; COCAINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; TUMOR MARKER;

ADULT; ARTICLE; CHROMATOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; INSULINOMA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE SYSTEM; NEUROENDOCRINE TUMOR; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION;

EID: 42049109293     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1946     Document Type: Article

References (39)

1. Langley K 1994 The neuroendocrine concept today. Ann NY Acad Sci 733:1-17
2. Polak JM, Bloom SR 1986 Regulatory peptides of the gastrointestinal and respiratory tracts. Arch Int Pharmacodyn Ther 280(Suppl 2):16-49
3. Taheri S, Meeran K 2000 Islet cell tumors: diagnosis and medical management. Hosp Med 61:824-829
4. Barakat MT, Meeran K, Bloom SR 2004 Neuroendocrine tumours. Endocr Relat Cancer 11:1-18
5. Modlin IM, Lye KD, Kidd M 2003 A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97:934-959
6. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK 1998 Carcinoid tumour. Lancet 352:799-805
7. Murphy KG 2005 Dissecting the role of cocaine- and amphetamine-regulated transcript (CART) in the control of appetite. Brief Funct Genomic Proteomic 4:95-111
8. Douglass J, Daoud S 1996 Characterization of the human cDNA and genomic DNA encoding CART: a cocaine- and amphetamine-regulated transcript. Gene 169:241-245
9. Dylag T, Kotlinska J, Rafalski P, Pachuta A, Silberring J 2006 The activity of CART peptide fragments. Peptides 27:1926-1933
10. Stein J, Steiner DF, Dey A 2006 Processing of cocaine- and amphetamine-regulated transcript (CART) precursor proteins by prohormone convertases (PCs) and its implications. Peptides 27:1919-1925
11. Koylu EO, Balkan B, Kuhar MJ, Pogun S 2006 Cocaine and amphetamine regulated transcript (CART) and the stress response. Peptides 27:1956-1969
12. Wierup N, Sundler F 2006 CART is a novel islet regulatory peptide. Peptides 27:2031-2036
13. Hunter RG, Philpot K, Vicentic A, Dominguez G, Hubert GW, Kuhar MJ 2004 CART in feeding and obesity. Trends Endocrinol Metab 15:454-459
14. Jensen PB, Kristensen P, Clausen JT, Judge ME, Hastrup S, Thim L, Wulff BS, Foged C, Jensen J, Holst JJ, Madsen OD 1999 The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans. FEBS Lett 447:139-143
15. Vicentic A 2006 CART peptide diurnal variations in blood and brain. Peptides 27:1942-1948
16. Stanley SA, Murphy KG, Bewick GA, Kong WM, Opacka-Juffry J, Gardiner JV, Ghatei M, Small CJ, Bloom SR 2004 Regulation of rat pituitary cocaine-and amphetamine-regulated transcript (CART) by CRH and glucocorticoids. Am J Physiol Endocrinol Metab 287:E583-E590
17. Reichlin M 1980 Use of glutaraldehyde as a coupling agent for proteins and peptides. Methods Enzymol 70:159-165
18. Sekiya K, Ghatei MA, Salahuddin MJ, Bishop AE, Hamid QA, Ibayashi H, Polak JM, Bloom SR 1989 Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value. J Clin Invest 83:1834-1842
19. Bishop AE, Bretherton-Watt D, Hamid QA, Fahey M, Shepherd N, Valentino K, Tatemoto K, Ghatei MA, Bloom SR, Polak JM 1988 The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system. Mol Cell Probes 2:225-235
20. Patterson M, Murphy KG, le Roux CW, Ghatei MA, Bloom SR 2005 Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab 90:2205-2211
21. Murphy KG, Abbott CR, Mahmoudi M, Hunter R, Gardiner JV, Rossi M, Stanley SA, Ghatei MA, Kuhar MJ, Bloom SR 2000 Quantification and synthesis of cocaine- and amphetamine-regulated transcript peptide (79-102)-like immunoreactivity and mRNA in rat tissues. J Endocrinol 166:659-668
22. O'Connor DT, Deftos LJ 1986 Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 314:1145-1151
23. Taupenot L, Harper KL, O'Connor DT 2003 The chromogranin- secretogranin family. N Engl J Med 348:1134-1149
24. Sobol RE, Memoli V, Deftos LJ 1989 Hormone-negative, chromogranin A-positive endocrine tumors. N Engl J Med 320:444-447
25. Bajetta E, Ferrari L, Martinetti A, Celio L, Procopio G, Artale S, Zilembo N, Di BM, Seregni E, Bombardieri E 1999 Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer 86:858-865
26. Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, De Herder WW, Krenning EP, Bouillon R, Lamberts SW 1997 Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the α-subunit of glycoprotein hormones. J Clin Endocrinol Metab 82:2622-2628
27. Stridsberg M, Eriksson B, Oberg K, Janson ET 2003 A comparison between three commercial kits for chromogranin A measurements. J Endocrinol 177:337-341
28. Kirshbom PM, Kherani AR, Onaitis MW, Feldman JM, Tyler DS 1998 Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids. Surgery 124:1063-1070
29. Portela-Gomes GM, Stridsberg M, Johansson H, Grimelius L 1997 Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract. J Histochem Cytochem 45:815-822
30. Wiedenmann B, Waldherr R, Buhr H, Hille A, Rosa P, Huttner WB 1988 Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin A, secretogranin I (chromogranin B), and secretogranin II. Gastroenterology 95:1364-1374
31. Stridsberg M, Eriksson B, Fellstrom B, Kristiansson G, Tiensuu JE 2007 Measurements of chromogranin B can serve as a complement to chromogranin A. Regul Pept 139:80-83
32. Nehar D, Lombard-Bohas C, Olivieri S, Claustrat B, Chayvialle JA, Penes MC, Sassolas G, Borson-Chazot F 2004 Interest of chromogranin A for diagnosis and follow-up of endocrine tumours. Clin Endocrinol (Oxf) 60:644-652
33. Angelsen A, Syversen U, Haugen OA, Stridsberg M, Mjolnerod OK, Waldum HL 1997 Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings? Prostate 30:1-6
34. Berruti A, Dogliotti L, Mosca A, Bellina M, Mari M, Torta M, Tarabuzzi R, Bollito E, Fontana D, Angeli A 2000 Circulating neuroendocrine markers in patients with prostate carcinoma. Cancer 88:2590-2597
35. Vicentic A, Dominguez G, Hunter RG, Philpot K, Wilson M, Kuhar MJ 2004 Cocaine- and amphetamine-regulated transcript peptide levels in blood exhibit a diurnal rhythm: regulation by glucocorticoids. Endocrinology 145:4119-4124
36. Kuhar MJ, Yoho LL 1999 CART peptide analysis by Western blotting. Synapse 33:163-171
37. Yanik T, Dominguez G, Kuhar MJ, Del Giudice EM, Loh YP 2006 The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans. Endocrinology 147:39-43
38. Thim L, Kristensen P, Nielsen PF, Wulff BS, Clausen JT 1999 Tissue-specific processing of cocaine- and amphetamine-regulated transcript peptides in the rat. Proc Natl Acad Sci USA 96:2722-2727
39. Koylu E, Erdogan M, Erdogan M, Karadeniz M, Saygili F, Balkan B, Pogun S, Kuhar M, Plasma CART peptide levels in thyroid patients: body mass Index, gender, and age-related changes. 36th Annual Meeting of the Society of Neuroscience, Atlanta, GA 2006 (Poster 003)